Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schulman

Showing results (171-180 of 240) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumorsD R Budman, L N Igwemezie, S Kaul, et al.
JACC. Case Reports|July 28, 2021
Crossing the Bridge to Heart Transplantation: Biventricular Impella to Support an Unstable LVAD PatientJoban Vaishnav, Steven Hsu, Kavita Sharma, et al.
International Journal of Cardiology|August 27, 2019
Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: Results from the OmniHeart trialLara C Kovell, Edwina H Yeung, Edgar R Miller, et al.
The American Journal of Cardiology|June 30, 2012
Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptorsRhondalyn C McLean, Stacy W Baird, Lewis C Becker, et al.
Blood|May 1, 1987
Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B studyH Preisler, R B Davis, J Kirshner, et al.
Journal of the American Geriatrics Society|April 1, 1996
No increased risk of Taxol toxicity in older patientsS M Lichtman, W Zaheer, D Gal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatinJ H Marsh, W Kreis, B Barile, et al.
Autoimmunity|January 1, 1994
IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewingM Wakai, S Hashimoto, M Omata, et al.
Cancer Research|April 1, 1985
Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancerG F Stanton, V Raymond, R E Wittes, et al.
Investigational New Drugs|August 1, 1990
Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing scheduleD R Budman, W Kreis, J Behr, et al.
Pageof 24

Showing results (171-180 of 240) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumorsD R Budman, L N Igwemezie, S Kaul, et al.
JACC. Case Reports|July 28, 2021
Crossing the Bridge to Heart Transplantation: Biventricular Impella to Support an Unstable LVAD PatientJoban Vaishnav, Steven Hsu, Kavita Sharma, et al.
International Journal of Cardiology|August 27, 2019
Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: Results from the OmniHeart trialLara C Kovell, Edwina H Yeung, Edgar R Miller, et al.
The American Journal of Cardiology|June 30, 2012
Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptorsRhondalyn C McLean, Stacy W Baird, Lewis C Becker, et al.
Blood|May 1, 1987
Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B studyH Preisler, R B Davis, J Kirshner, et al.
Journal of the American Geriatrics Society|April 1, 1996
No increased risk of Taxol toxicity in older patientsS M Lichtman, W Zaheer, D Gal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatinJ H Marsh, W Kreis, B Barile, et al.
Autoimmunity|January 1, 1994
IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewingM Wakai, S Hashimoto, M Omata, et al.
Cancer Research|April 1, 1985
Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancerG F Stanton, V Raymond, R E Wittes, et al.
Investigational New Drugs|August 1, 1990
Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing scheduleD R Budman, W Kreis, J Behr, et al.
Pageof 24